Raj Bawa is president of Bawa Biotech LLC, a biotech/pharma consultancy and patent law firm based in Ashburn, VA, USA that he founded in 2002. He is an inventor, entrepreneur, professor and registered patent agent licensed to practice before the U.S. Patent & Trademark Office. Trained as a biochemist and microbiologist, he has been an active researcher for over two decades. He has extensive expertise in pharmaceutical sciences, biotechnology, nanomedicine, drug delivery and biodefense, FDA regulatory issues, and patent law. Since 1999, he has held various positions at Rensselaer Polytechnic Institute in Troy, NY, where he is currently an adjunct professor of biological sciences and where he received his doctoral degree in three years (biophysics/biochemistry). Since 2004, he has been an adjunct professor of natural and applied sciences at NVCC in Annandale, VA. He is a scientific advisor to Teva Pharmaceutical Industries, Ltd., Israel. He has served as a principal investigator of National Cancer Institute SBIRs and reviewer for both the NIH and NSF. In the 1990s, Dr. Bawa held various positions at the US Patent & Trademark Office, including primary examiner for 6 years. He is a life member of Sigma Xi, co-chair of the Nanotech Committee of the American Bar Association and serves on the global advisory council of the World Future Society. He is frequently interviewed by the media and appeared in such publications as Nature, MIT Technology Review, American Chemical Socitye CE&N, Business Review, etc. He has authored over 100 publications, co-edited four texts and serves on the editorial boards of 17 peer-reviewed journals, including serving as a Special Associate Editor of Nanomedicine (Elsevier) and an Editor-in-Chief of the Journal of Interdisciplinary Nanomedicine (Wiley). Some of Dr. Bawa’s awards include the Innovations Prize from the Institution of Mechanical Engineers, London, UK (2008); Appreciation Award from the Undersecretary of Commerce, Washington, DC (2001); the Key Award from Rensselaer’s Office of Alumni Relations (2005); and Lifetime Achievement Award from the American Society for Nanomedicine (2014).
He is the principal investigator at the Laboratoty of Immunobiology at Federal University of Rio de Janeiro, Associate Professor at Federal University of Rio de Janeiro, and a Senior Research Specialist from the Presidency of the Oswaldo Cruz Foundation-FIOCRUZ where he investigate the immunological mechanisms associated with changes in central and peripheral lymphoid system in infectious diseases, with major focus in Malaria, Leishmaniasis and Chagas Diseases.
Noah Isakov is a Professor of Immunology in the Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, at Ben Gurion University of the Negev, in Beer Sheva, Israel, where he holds the Joseph H Krupp Chair in Cancer Immunobiology. He obtained his PhD from the Weizmann Institute of Science in Rehovot, Israel (1981) and worked as a postdoctoral researcher at the University of Minnesota in Minneapolis, MN (1981-1983) and the Scripps Research Institute in La Jolla, CA (1983-1987). He performed sabbaticals at the NICHD, National Institutes of Health in Bethesda, MD (1993-1995), the Oklahoma Medical Research Foundation in Oklahoma City, OK (2003-2004), where he held the Esther Greenberg Honors Chair in Biomedical Research, and the Otago University in Dunedin, New Zealand (2015).
Aziz Alami Chentoufi is a Consultant and Head of Immunology/Serology/HLA section at Pathology and Clinical Laboratory Medicine, King Fahad Medical City (KFMC). He is also an Assistant Professor of Immunology at Faculty of Medicine, King Saud Ibn AbdulAziz University. He is the Chairperson of Research Committee of PCLMA-KFMC. He is the Diplomate of the American Board of Medical laboratory Immunology D(ABMLI ), Fellow of the Association of Clinical Sciences (FACSc), accredited by the European Society of Translational Medicine (PCTM) and Fellow of the Academy of translational Medicine (FacadTM). He received his Ph.D. in Biomedical Sciences (Tolerance induction to xenogenic and allogenic antigens using monoclonal antibody anti-igM and anti-IgD) from the University Catholic of Louvain, Brussels, Belgium in 1999. He has done postdoctoral fellowship at McGill University, Montreal, Canada from 1999 to 2004 where he worked on immunogenetic of type 1 Diabetes and gene therapy for graft versus host disease then he was appointed as specialist at the University of California Irvine-Medical Center, Irvine, California, USA in 2006 where he was a key investigator in the development of mucosal vaccine against herpes simplex virus type 1 and 2.
Yaffa Mizrachi Nebenzahl has completed her PhD at The Weizmann Institute, Israel in 1985. She is the Head of the Molecular Microbiology Laboratory in The Shraga Segal Department of Microbiology, Immunology and Genetics at the Faculty of Health Sciences in Ben Gurion University of the Negev, Israel.
Immunology, molecular biology, infectious diseases, bio chemistry, pneumonia, innate Immunity.
? 1996 - Present (Total 21+ years) ? Founder Director Swasthya Santulan Medicare Pvt.Ltd. ? Working as Consulting Acupuncturist ? 2000- Present ? Founder, Director, Head of Management and Teacher, School of Alternative Healing and Acupuncture Insync ( Saheacci), Pune ? 2013-Present ? Authorized Teacher in Acupuncture for Beijing Mebo Training Centre, China for 8 advanced courses in Pulse Diagnosis ? 2016 - Present ? Authorized trainer for NADA ? 2017 ? Lecturer in Acupuncture at University of Perugia, Italy. ? 2017 ? Official Trainer
? March 2017- 1st Indian Woman Acupuncturist to represent India, at United Nations, through (All Shah Behrum Baug Society, Mumbai, recognized as consultative status at UN) for research in Acupuncture in New York in CSW 61, Commission on Status of Women. ? January 2017- First Indian Acupuncturist to introduce the philosophy of Acupuncture at University Of Perugia, Italy. Invited for a key talk on Pulse diagnosis in Acupuncture at Medicine department as well as Nursing department at Perugia and Foligno University, Italy. ? October 2016- First Indian woman Acupuncturist to be invited as a keynote speaker at Chicago, at International Restorative Medicine Conference. ? September 2016- First Indian Woman Acupuncturist to present a research paper at Netherlands in International Traditional Medicine symposium, Amsterdam, Netherlands. ? First Indian woman Acupuncturist to be appointed as an Organising Committee Member, Moderator, and Trainer for 2nd International Restorative Medicine Conference at Vienna, Austria 2017 and Paris 2018. ? 2013- Presented research paper on “Collagen induced arthritis and Acupuncture” at the 6th International conference on Natural Medicine at Paris, France. ? 2003-2017 Researched and presented more than 800 lectures, creating Acupuncture awareness in different social organizations in India and abroad. ? 2005-2014 300+ free treatment camps in rural areas of Maharashtra. ? 2012 Presented Research paper on ‘Convulsions due to cochlear Implantation and Acupuncture healing’ at the 19th International conference of alternative medicine, Kolkata. ? 2010 Presented Research paper on ‘Convulsions due to cochlear Implantation and Acupuncture